Generic Substitution of Orphan Drugs for the Treatment of Rare Diseases: Exploring the Potential Challenges

Drugs
Antonello Di Paolo, Elena Arrigoni

Abstract

Generic drugs are important components of measures introduced by healthcare regulatory authorities to reduce treatment costs. In most patients and conditions the switch from a branded drug to its generic counterpart is performed with no major complications. However, evidence from complex diseases suggests that generic substitution requires careful evaluation in some settings and that current bioequivalence criteria may not always be adequate for establishing the interchangeability of branded and generic products. Rare diseases, also called orphan diseases, are a group of heterogeneous diseases that share important characteristics: in addition to their scarcity, most are severe, chronic, highly debilitating, and often present in early childhood. Finding a treatment for a rare disease is challenging. Thanks to incentives that encourage research and development programs in rare diseases, several orphan drugs are currently available. The elevated cost of orphan drugs is a highly debated issue and a cause of limited access to treatment for many patients. As patent protection and the exclusivity period of several orphan drugs will expire soon, generic versions of orphan drugs should reach the market shortly, with great expectations a...Continue Reading

References

Jan 1, 1988·Annual Review of Biochemistry·T W RademacherR A Dwek
Apr 15, 1995·Analytical Chemistry·R S RushV Katta
Sep 17, 1998·Archives of Internal Medicine·J CharrowJ S Wisch
Aug 29, 2001·Clinical Pharmacokinetics·K Mahalati, B D Kahan
Sep 19, 2003·The New England Journal of Medicine·Gregory L KearnsRalph E Kauffman
Dec 25, 2003·Clinical Therapeutics·Peter Meredith
Oct 6, 2005·QJM : Monthly Journal of the Association of Physicians·D A HughesS T Yeo
Jan 18, 2006·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·R K VerbeeckR B Walker
Feb 17, 2006·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Manjunath P PaiGuy W Amsden
Mar 1, 2006·Seizure : the Journal of the British Epilepsy Association·P CrawfordG Kramer
May 24, 2006·World Journal of Gastroenterology : WJG·Christina MaserSanziana Roman
Sep 8, 2006·Pharmacoepidemiology and Drug Safety·Carla Maria Teixeira de Barros, Ana Luísa Papoila
Sep 18, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H MellstedtH Ludwig
Nov 21, 2007·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·S Aymé, J Schmidtke
Dec 7, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Huub Schellekens
Apr 22, 2008·European Journal of Public Health·Astrid Milde-BuschRüdiger von Kries
Jun 17, 2008·Lancet·Arrigo SchieppatiAnita Aperia
Jul 30, 2008·Current Treatment Options in Oncology·Stuart M Lichtman, Manpreet K Boparai
Apr 11, 2009·Journal of Neurology·Thomas Meier, Gunnar Buyse
Oct 13, 2009·Drug Discovery Today·Harald E HeemstraRemco L A de Vrueh
Mar 23, 2010·Current Medical Research and Opinion·Paul J DeclerckMichael B Ranke
Jun 10, 2010·Nature Reviews. Drug Discovery·M Miles BraunTimothy R Coté
Aug 14, 2010·American Journal of Hematology·Wolfgang Jelkmann
Oct 20, 2010·Expert Opinion on Drug Metabolism & Toxicology·Claudia BeckerJuergen Drewe
Nov 10, 2010·Nature Reviews. Drug Discovery·Erik Tambuyzer
Dec 15, 2010·European Journal of Medical Genetics·Raoul C M Hennekam
Jan 21, 2011·Science Translational Medicine·Edward Connor, Pablo Cure
Mar 25, 2011·Kidney International·Kearkiat PraditpornsilpaSomchai Eiam-Ong
Sep 29, 2011·Orphanet Journal of Rare Diseases·Carina ScheyAdam Hutchings
Dec 17, 2011·Journal of Transplantation·A K Singh, S S Narsipur
Feb 2, 2012·Expert Opinion on Pharmacotherapy·Michelangelo MancusoGabriele Siciliano
Mar 31, 2012·Nature Reviews. Drug Discovery·Irena Melnikova
Aug 31, 2012·Statistics in Medicine·Shein-Chung ChowPeter A Lachenbruch
Sep 18, 2012·Drug Discovery Today·Pedro Franco
Oct 24, 2012·European Journal of Clinical Pharmacology·Roberta JoppiSilvio Garattini
Dec 12, 2012·The New England Journal of Medicine·Janet WoodcockLawrence X Yu
Dec 25, 2012·The Journal of Clinical Endocrinology and Metabolism·Jeremi M CarswellRosalind S Brown
Apr 5, 2013·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Asterios S TsiftsoglouChristian K Schneider
Jul 13, 2013·Applied Health Economics and Health Policy·Pieter DylstSteven Simoens
Aug 21, 2013·Orphanet Journal of Rare Diseases·Tim A KantersLeona Hakkaart
Nov 19, 2013·Orphanet Journal of Rare Diseases·Michelle PutzeistRemco L A de Vrueh
Jan 18, 2014·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Michael Drummond, Adrian Towse
Feb 15, 2014·Orphanet Journal of Rare Diseases·Adam HutchingsKarolina Antonov
Feb 25, 2014·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Mario L de Lemos, Victoria Kyritsis

❮ Previous
Next ❯

Citations

Dec 19, 2020·International Journal of Environmental Research and Public Health·Lei ChenZongfu Mao
May 22, 2018·Trends in Pharmacological Sciences·Misty M AttwoodHelgi B Schiöth

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
M KandelP Paubel
Materia Medica Polona. Polish Journal of Medicine and Pharmacy
T Szuba
Orphanet Journal of Rare Diseases
Enrique Seoane-VazquezJay Visaria
© 2022 Meta ULC. All rights reserved